Pfizer 2Q Revenues: $11.8 billion (-7%) 2Q Earnings: $2.6 billion (-10%) YTD Revenues: $22.7 billion (-6%) YTD Earnings: $5.0 billion (-5%) Comments: Global Innovative Pharmaceutical segment sales were $3.5 billion in the quarter, down 1%. Global Vaccines sales were $1.6 billion, up 44% driven by Prevnar 13, up 87% in the U.S., and 25% internationally. Global Oncology sales were $713 million, up 25% driven by the U.S. launch of Ibrance for advanced breast cancer and, to a lesser e...